US Drug Recall Register
Class III · Low risk Terminated Initiated Sep 20, 2017 (9 years ago)

Fluocinonide Gel USP

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Cross contamination with other products: traces of Dapsone were found in the finished product.

What was recalled

Fluocinonide Gel USP, 0.05%, 15 g tube, Rx Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton Ontario Canada L6T1C1, Dist. by: Taro Pharmaceuticals U.S.A . Inc. Hawthorne NY 10532, NDC 51672-1279-1

Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
NDC code
51672-1279-1
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0146-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Fluocinonide recalls

See all
Class II · Moderate risk Ongoing

Fluocinonide

Reason Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Sun Pharmaceutical Industries INC NDC 51672-1386-3 D-0477-2026
Class II · Moderate risk Ongoing

Fluocinonide

Reason Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Sun Pharmaceutical Industries INC NDC 51672-1386-2 D-0476-2026
Class II · Moderate risk Ongoing

Fluocinonide

Reason Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Sun Pharmaceutical Industries INC NDC 51672-1386-1 D-0475-2026
Class II · Moderate risk Terminated

Fluocinonide Topical Solution USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-025-20 D-0685-2022
Class II · Moderate risk Terminated

Fluocinonide Gel USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-054-15 D-0684-2022